• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

New Drug Shows Promise in MS (Monoclonal Antibody that targets CD20 on B Cells!)

shannah

Senior Member
Messages
1,429
Noteworthy:

"For decades, work in the field has focused on targeting one component of the immune system the T cells which were always seen as the smoking gun of the disease because they attack nerve fibers in the brain, causing the lesions and ultimately the symptoms of multiple sclerosis. Ocrelizumab, in contrast, targets a molecule called CD20 found on the surface of B cells, a separate component of the immune system."
 

mellster

Marco
Messages
805
Location
San Francisco
Slightly off-topic, but Montel is on Dr Oz talking about his struggles with MS - he has been eventually helped tremendously by medical marijuana.
 

dsdmom

Senior Member
Messages
397
Noteworthy:

"For decades, work in the field has focused on targeting one component of the immune system the T cells which were always seen as the smoking gun of the disease because they attack nerve fibers in the brain, causing the lesions and ultimately the symptoms of multiple sclerosis. Ocrelizumab, in contrast, targets a molecule called CD20 found on the surface of B cells, a separate component of the immune system."

This is exactly what Rituxan does - ocrelizumab is just a newer version of it. For the pharma company to keep making money once their patent expires in 2015.
 
Messages
6
This is exactly what Rituxan does - ocrelizumab is just a newer version of it. For the pharma company to keep making money once their patent expires in 2015.

For me, the upshot of this article is that a bonafide autoimmune condition (MS) responds favorably to a monoclonal antibody. My sister has MS, my daughter CFIDS.
 

dsdmom

Senior Member
Messages
397
So yesterday I had a long conversation about rituxan with a specialty pharmacist where I get ivig. I was surprised to hear that he has many ms patients on rituxan since I did not think insurance paid for it as it is not specifically indicated for ms. He told me that it requires a prior auth and depends on the insurance but there definitely are patients receiving it for ms. That said, I do not know anything about the patients and their forms of ms.